Lifevantage Corp SEC filings LFVN
Lifevantage Corp has 1,001 filings in SEC EDGAR's recent list, going back to Oct 28, 2009. Its latest annual report, Form ARS, was filed on Sep 18, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 6, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 18, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2026 | — |
| DFAN14A | Filing | Nov 2, 2023 | — |
| DFAN14A | Filing | Oct 30, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2023 | — |
| DFAN14A | Filing | Oct 27, 2023 | — |
| DFAN14A | Filing | Oct 26, 2023 | — |
| DFAN14A | Filing | Oct 25, 2023 | — |
| DFAN14A | Filing | Oct 19, 2023 | — |
| DFAN14A | Filing | Oct 13, 2023 | — |
| DFAN14A | Filing | Oct 12, 2023 | — |
| DFAN14A | Filing | Sep 26, 2023 | — |
| DEFC14A | Filing | Sep 25, 2023 | — |
| DEFC14A | Filing | Sep 22, 2023 | — |
| PREC14A | Filing | Sep 15, 2023 | — |
| PREC14A | Filing | Sep 8, 2023 | — |
| 8-A12B | Filing | Aug 31, 2023 | — |
| EFFECT | Filing | Apr 6, 2023 | — |
| CORRESP | Letter to the SEC | Apr 4, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2023 | — |
| EFFECT | Filing | Apr 3, 2020 | — |
| CORRESP | Letter to the SEC | Apr 1, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2020 | — |
| 8-A12B/A | Filing | Mar 13, 2018 | — |
| NT 10-Q | Filing | Nov 10, 2016 | Sep 30, 2016 |
| NT 10-K | Filing | Sep 13, 2016 | Sep 13, 2016 |
| CT ORDER | Filing | Oct 2, 2014 | — |
| CT ORDER | Filing | Jul 7, 2014 | — |
| SC TO-I/A | Filing | Oct 31, 2013 | — |
| SC TO-I/A | Filing | Oct 28, 2013 | — |
| SC TO-C | Credit facility | Oct 18, 2013 | — |
| SC TO-I/A | Filing | Oct 18, 2013 | — |
| CORRESP | Letter to the SEC | Sep 27, 2013 | — |
| SC TO-I/A | Amendment no. 1 | Sep 27, 2013 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2013 | — |
| SC TO-I | Filing | Sep 24, 2013 | — |
| SC TO-C | Schedule to-c | Sep 24, 2013 | — |
| SC TO-C | Filing | Sep 13, 2013 | — |
| SC TO-C | Filing | Sep 12, 2013 | — |
| CT ORDER | Filing | Aug 2, 2013 | — |
| CERTNAS | Auto-generated paper document | Sep 11, 2012 | — |
| 8-A12B | Form 8-a | Sep 11, 2012 | — |
| CT ORDER | Filing | Feb 10, 2012 | — |
| SC TO-I/A | Amendment no. 2 to schedule to-i | Dec 30, 2011 | — |
| SC TO-I/A | Amendment no. 1 to schedule to-i | Dec 20, 2011 | — |
| SC TO-I | Schedule to | Nov 29, 2011 | — |
| D | Filing | Feb 10, 2010 | — |
Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LFVN (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Lehi, UT
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 849146
- Former names
- LIFELINE THERAPEUTICS, INC. (until Dec 6, 2006); YAAK RIVER RESOURCES INC (until Sep 28, 2004)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.